US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted A61KA61K31/519A61K45/06
Quick answer
US patent 12427148 (Cancer treatment targeted to tumor adaptive responses to protein synthesis stress) held by The Regents of the University of California expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/519, A61K45/06, A61P, A61P35/02